Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2022-04-14 00:00:00 ET · period of report 2021-05-28 · accession 0001567619-22-008545 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-14 | 2021-05-28 | IDYA | Stone Paul A. | SVP, CFO | A - Grant | $11.36 | +859 | 13.8K | +7% | +$9,758 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-05-28 | A | A | 859 | $11.36 | 13,803 | D | — | — | (F1) Acquired pursuant to Issuer's Employee Stock Purchase Plan. |